This inventor holds 1 USPTO granted patent. Top assignee: Vogenx. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Wiliam Owen Wilkison: Innovator in Metabolic Disease Treatment
Introduction
Wiliam Owen Wilkison is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of metabolic disease treatment through his innovative patent.
Latest Patents
Wiliam holds a patent for "Compositions and methods for treating metabolic disease." This invention relates to oral dosage form therapies that utilize combinations of inhibitors of SGLT1 and SGLT2. The patent describes how SGLT1 is effective in the intestinal lumen while being poorly absorbed, and how the SGLT2 inhibitor works to inhibit sugar reabsorption in the kidney. The combined use of these inhibitors addresses metabolic disorders associated with abnormal liver lipid accumulation and hyperglycemia.
Career Highlights
Wiliam is currently associated with Vogenx, where he continues to work on innovative solutions for metabolic disorders. His expertise in this area has positioned him as a key figure in the development of effective therapies.
Collaborations
Wiliam collaborates with talented individuals such as James Trinca Green and Yoshikazu Fujimori, contributing to a dynamic research environment focused on advancing treatment options.
Conclusion
Wiliam Owen Wilkison's work in developing therapies for metabolic diseases showcases his commitment to innovation and improving patient outcomes. His contributions are vital in the ongoing fight against metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile